This ad will auto close in 10 seconds

FDA hikes fee for drug approvals, cuts unit inspection charge

However, the fees for facility inspection of foreign companies have been reduced, which may encourage more firms to opt for audit of their facilities by the regulator.

Govt to come with plans to improve bulk drug manufacturing capacities

The government will shortly come out with strategies to improve bulk drug manufacturing capacity in India in order to reduce dependence on China for import of bulk drugs.

India pitches for review of US pharma whistle blower policy

Taking up the case of domestic pharma sector with the US, India has pitched for review of America's whistle blower policy and lowering of registration charges to help Indian firms seek greater market access.

Pharma cos to witness 26% core sales growth in Q3: BoAML

BoAML said it sees strong base business growth at Sun, Dr Reddy, Lupin and Aurobindo Pharma.

Govt may review FDI policy in pharma, housing today

The Cabinet would also deliberate on the stand to be taken by India in the forthcoming WTO meet in Bali between December 3-6.

FIPB clears 6 pharma proposals worth Rs 855 cr

The Foreign Investment Promotion Board (FIPB) Monday cleared six proposals envisaging investments of Rs 855 crore in the pharmaceutical sector, including one by Fresenius Kabi.

US, EU slowdown may keep pharma export growth at 10%: Official

Pharmaceutical exports from India is expected to remain in the range of 10 to 11 percent in the current fiscal as slowdown in some of the key markets such as North America and Europe continue to cause concern to exporters, a senior government official said.

'Policy, infrastructure main hurdles in Indian pharma R&D'

The Indian healthcare sector has tripled in size in the last decade from USD 23 billion in 2002 to USD 70 billion today.

Pharma exports rise 10% to $14.6 bn in FY’13

Pharma exports grew by 10.55 percent year-on-year to USD 14.6 billion during the financial year 2012-13, a top official of industry body Pharmexcil said.

Takeover of local pharma cos by foreign firms a concern: Sharma

Government welcomes foreign direct investments into the pharma sector but there are concerns that generic drugs market could be adversely hit if overseas players fully acquire local companies, Commerce and Industry Minister Anand Sharma said Monday.

New drug policy to negatively impact pharma sector: Industry

The just-notified new drug price control policy will negatively impact sales and margins of pharmaceutical firms in India, according to industry players.

Indian pharma industry seeks policy reforms in Indonesia

India hopes the Indonesian government will undertake policy reforms that will enable Indian companies to invest in the South-East Asian nation's pharmaceutical sector.

India woos Iran with its affordable generic drugs

India is hard selling its cost effective generic drugs to Iran and competing against the expensive medicines from Europe.

Pharma M&As set to gather more steam in 2013: report

The activities on the M&A street in the pharma space in the recent past are likely to gather more steam through 2013, says a research report.

Pharma industry unhappy with Govt decision on FDI

Pharmaceutical industry Tuesday criticised the government's decision to make it mandatory for all foreign investments in existing domestic pharma firms to be cleared by the FIPB.

All FDI in domestic pharma cos to be cleared by FIPB

The government Monday decided that all foreign investments in existing domestic pharma firms should be allowed only after clearance by the FIPB, amid mounting concerns over availability of affordable essential drugs in the wake of multinationals acquiring local companies.

Indian pharma cos market revenue share up at 32% in Q2 FY13

he Indian pharma market continued its strong performance owing to a jump in revenue from the domestic market and new product launches.

Govt approves drug pricing policy to lower cost of medicines

The government on Thursday cleared the National Pharmaceutical Pricing Policy that will bring 348 essential drugs under price control, leading to reduction in prices.

Pharma exports to touch $25 bn by 2014-15

Amid global economic concerns, the pharma exports are expected to reach USD 25 billion by 2014-15, a senior government official said Wednesday.

Cabinet defers decision on new pharma pricing policy

The Cabinet Thursday deferred the decision on the draft pharmaceutical pricing policy that aims to increase the number of essential medicines under price control from 74 to 348.